Have any questions? 706-721-6582 or cts@augusta.edu
Study Name | Principal Investigator |
---|---|
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinson’s Disease | Morgan, John |